The dual PI3K/mTOR inhibitor NVP-BGT226 induces cell cycle arrest and regulates Survivin gene expression in human pancreatic cancer cell lines

Regulation of survivin by PI3K/Akt/p70S6K1 pathway

(2010) Peng Zhao et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitor

(2010) Matthew R Janes et al.   NATURE MEDICINE

Pancreatic Cancer

(2010) Manuel Hidalgo   NEW ENGLAND JOURNAL OF MEDICINE

Targeting mTOR: prospects for mTOR complex 2 inhibitors in cancer therapy

(2010) C A Sparks et al.   ONCOGENE

The Role of Apoptosis in the Pathology of Pancreatic Cancer

(2010) Nicole Samm et al.   Cancers

Inhibiting PI3K as a therapeutic strategy against cancer

(2009) Luis Paz-Ares et al.   Clinical & Translational Oncology

Implication of the Akt2/survivin pathway as a critical target in paclitaxel treatment in human ovarian cancer cells

(2008) Danhui Weng et al.   CANCER LETTERS

siRNA Directed Against Survivin Enhances Pancreatic Cancer Cell Gemcitabine Chemosensitivity

(2008) Wen-Song Liu et al.   DIGESTIVE DISEASES AND SCIENCES

The PTEN–PI3K pathway: of feedbacks and cross-talks

(2008) A Carracedo et al.   ONCOGENE